Vanrompay D, Cox E, Volckaert G, Goddeeris B
Clin Exp Immunol. 1999; 118(1):49-55.
PMID: 10540159
PMC: 1905387.
DOI: 10.1046/j.1365-2249.1999.01024.x.
Hormaeche C, Fahrenkrog M, Pettifor R, Brock J
Immunology. 1981; 43(3):547-54.
PMID: 7019057
PMC: 1555054.
Carpenter A, Sully E, Palcanis K, Bick P
Infect Immun. 1983; 42(3):853-62.
PMID: 6642667
PMC: 264377.
DOI: 10.1128/iai.42.3.853-862.1983.
Chen Y, Heller P
Clin Exp Immunol. 1981; 45(3):514-22.
PMID: 6461449
PMC: 1537407.
Rooney C, Munro A
Immunology. 1984; 51(1):193-9.
PMID: 6418639
PMC: 1454391.
Diffusible suppressor factor from splenic macrophages in murine plasmacytoma.
Chen Y, Heller P
Clin Exp Immunol. 1984; 57(1):171-7.
PMID: 6378461
PMC: 1536073.
Immunosuppression in plasmacytoma: induction of suppressor cells.
Chen Y, Hwang L, Heller P
Clin Exp Immunol. 1982; 47(1):191-6.
PMID: 6212173
PMC: 1536353.
The surface properties and antigen-presenting function of hepatic non-parenchymal cells.
Pulford K, Souhami R
Clin Exp Immunol. 1981; 46(3):581-8.
PMID: 6175463
PMC: 1536307.
Studies on antibody induction in vitro. II. Cellular requirements for a primary response to soluble T2 antigens by rabbit cell cultures.
Curley D, Adler L, Fishman M
Immunology. 1974; 27(4):553-62.
PMID: 4611904
PMC: 1445722.
Reconstitution of immunocompetence in B cells by addition of concanavalin A or concanavalin A-treated thymus cells.
Sjoberg O, Moller G, Andersson J
Clin Exp Immunol. 1973; 13(2):213-23.
PMID: 4571212
PMC: 1553715.
Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells.
Forman J, Britton S
J Exp Med. 1973; 137(2):369-86.
PMID: 4539847
PMC: 2139487.
DOI: 10.1084/jem.137.2.369.
Effect of allogeneic cell interaction on the primary immune response in vitro. Cell types involved in suppression and stimulation of antibody synthesis.
Sjoberg O
Clin Exp Immunol. 1972; 12(3):365-75.
PMID: 4404919
PMC: 1553593.
Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii.
Damrow T, Williams J, Waag D
Infect Immun. 1985; 47(1):149-56.
PMID: 3965392
PMC: 261490.
DOI: 10.1128/iai.47.1.149-156.1985.
Genetic analysis of lymphocyte activation by lipopolysaccharide Endotoxin.
SULTZER B
Infect Immun. 1976; 13(6):1579-84.
PMID: 1085749
PMC: 420803.
DOI: 10.1128/iai.13.6.1579-1584.1976.
Listeria cell wall fraction. Characterization of in vitro adjuvant activity.
Schuffler C, Campbell P
Immunology. 1976; 31(2):323-9.
PMID: 821854
PMC: 1445130.
The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
Watson S, Sljivic V
Clin Exp Immunol. 1976; 23(1):149-53.
PMID: 770033
PMC: 1538357.
Inhibition of Ehrlich ascites carcinoma (EAC) growth by carbonyl iron.
Pessina A, Brambilla P, Balzarin D
Experientia. 1978; 34(11):1518-9.
PMID: 720492
DOI: 10.1007/BF01932386.
Immunological senescence. I. The role of suppressor cells.
Roder J, Duwe A, Bell D, Singhal S
Immunology. 1978; 35(5):837-47.
PMID: 363607
PMC: 1457549.
Regulation of the immune response in autoimmune NZB/NZW F1 mice. II. Age dependent release of suppressive factors from spleen cells.
Roder J, Bell D, Singhal S
Immunology. 1978; 34(6):1017-26.
PMID: 355117
PMC: 1457411.
A re-evaluation of the role of macrophages in carrageenan-induced immunosuppression.
Rumjanek V, Watson S, Sljivic V
Immunology. 1977; 33(3):423-32.
PMID: 332622
PMC: 1445637.
